HRT Financial’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

HRT Financial’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-46,544	Closed	-$1.71M	–	3440
2022 Q4	$1.71M	Sell	46,544 -28,070	-38%	-$1.11M	0.02%	666
2022 Q3	$3.52M	Buy	74,614 +25,658	+52%	+$1.66M	0.04%	401
2022 Q2	$3.51M	Buy	+48,956	New	+$3.58M	0.04%	355
2021 Q3	–	Sell	-28,253	Closed	-$2.53M	–	3914
2021 Q2	$2.53M	Buy	+28,253	New	+$2.39M	0.02%	525
2021 Q1	–	Sell	-121,047	Closed	-$8.25M	–	3293
2020 Q4	$8.25M	Buy	+121,047	New	+$7.55M	0.17%	99
2020 Q3	–	Sell	-45,699	Closed	-$2.66M	–	2489
2020 Q2	$2.66M	Buy	+45,699	New	+$2.46M	0.08%	273
2019 Q4	–	Sell	-4,057	Closed	-$215K	–	1786
2019 Q3	$215K	Buy	+4,057	New	+$208K	0.01%	1110

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

HRT Financial's SYNH Position: Q1 2023 in Review

HRT Financial sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 46,544 shares — an estimated $1.71M sold.

HRT Financial first reported a position in SYNH in Q3 2019 and held it in 7 quarters. The position peaked at $8.25M in Q4 2020. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

HRT Financial reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
HRT Financial sold 46,544 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $1.71M.
HRT Financial first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 7 quarters.
HRT Financial's Syneos Health, Inc. Class A Common Stock position peaked at $8.25M in Q4 2020.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.